Snider De
Impact in
- Infectious Diseases top 5%
- Tuberculosis Research and Epidemiology
- Pharmacology top 5%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Tuberculosis Research and Epidemiology 9
-
- Drug-Induced Hepatotoxicity and Protection 1
- Pharmacogenetics and Drug Metabolism 1
- Co-authors
- Rieder Hl (1 shared paper)
- Journals
- New England Journal of Medicine (1 paper)PubMed (11 papers)
- Partner nations
- United States
In The Last Decade
Snider De
12 papers receiving 501 citations
Peers
Comparison fields: 5 of 74
- Infectious Diseases 365
- Pharmacology 133
- Epidemiology 266
- Surgery 190
- Hepatology 33
Countries citing papers authored by Snider De
This map shows the geographic impact of Snider De's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Snider De with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Snider De more than expected).
Fields of papers citing papers by Snider De
This network shows the impact of papers produced by Snider De. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Snider De. The network helps show where Snider De may publish in the future.
Co-authors
The 1 scholars most cited alongside Snider De, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1978 | 287 | |
| 2 | Tuberculosis morbidity in the United States: final data, 1990. | 1991 | 105 |
| 3 | Six-months isoniazid-rifampin therapy for pulmonary tuberculosis. Report of a United States Public Health Service Cooperative Trial. | 1984 | 47 |
| 4 | The epidemiology of tuberculosis in the United States. | 1989 | 46 |
| 5 | Tuberculosis: an increasing problem among minorities in the United States. | 1990 | 18 |
| 6 | Nosocomial tuberculosis in the AIDS era with an emphasis on multidrug-resistant disease. | 1993 | 14 |
| 7 | The global threat of drug-resistant tuberculosis [editorial] | 1998 | 8 |
| 8 | Short-course tuberculosis chemotherapy studies conducted in Poland during the past decade. | 1986 | 5 |
| 9 | [General view of problems with compliance in programs for the treatment of tuberculosis]. | 1983 | 4 |
| 10 | Reorientation of tuberculosis control programmes in the USA. | 1989 | 3 |
| 11 | Recognition and elimination of tuberculosis. | 1993 | 2 |
| 12 | Deciphering the data: race, ethnicity, and gender as critical variables. | 1996 | 2 |
About Snider De
Snider De is a scholar working on Infectious Diseases, Pharmacology, Surgery, Pediatrics, Perinatology and Child Health and Pulmonary and Respiratory Medicine, having authored 12 papers that have together received 541 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (9 papers), Poisoning and overdose treatments (1 paper), Pharmaceutical studies and practices (1 paper), Diagnosis and treatment of tuberculosis (1 paper), Epilepsy research and treatment (1 paper), Lung Cancer Treatments and Mutations (1 paper), Drug-Induced Hepatotoxicity and Protection (1 paper) and Pharmacogenetics and Drug Metabolism (1 paper). The work is most often cited by research in Infectious Diseases (365 citations), Pharmacology (133 citations), Epidemiology (266 citations), Surgery (190 citations) and Hepatology (33 citations). Snider De has collaborated with scholars based in United States. Frequent co-authors include Rieder Hl. Their work appears in journals such as New England Journal of Medicine and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.